The Carolina Pediatric Attention, Love, and Support program pairs UNC students with young people undergoing treatment for cancer and blood disorders, Josephine Yurcaba of the Daily Tar Heel reports.
Bruce Ham, one of the original members of the Single Fathers Due to Cancer support group, has written a memoir, “Laughter, Tears and Braids,” about his journey raising three daughters after the death of his wife from cancer.
The largest-ever population-based study of breast cancer in North Carolina is poised to begin the five year follow-up phase.
The Tuesday after Thanksgiving is intended to create a national movement around the holidays dedicated to giving.
A new study led by Christine Rini, PhD, finds that survivors of hematopoietic stem cell transplant, an aggressive treatment for blood cancers, benefited from a two-part peer support process the authors call expressive helping.
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, was quoted on National Public Radio's All Things Considered regarding the Food and Drug Administration's warning letter sent to the company 23andMe demanding that its saliva test be taken off the market.
Give back this holiday season by registering with Be The Match on UNC’s campus on December 2 and 3, 2013.
Stella Waugh, a cancer survivor, is thankful to have family together for Thanksgiving, April Dudash of the Durham Herald-Sun reports.
For the fifth straight year, UNC Libraries and campus collect books for the Pediatric Hematology-Oncology clinic.
A study of 2,519 Kenyan men conducted by researchers at the University of North Carolina revealed that infection with the human papillomavirus (HPV) was associated with a higher subsequent risk of infection with HIV, a precursor to AIDS.
A Dare County, N.C., wife and mother of three keeps her spunky, positive spirit intact during treatment for thyroid cancer, buoying herself, her family and her medical team on the journey.
William Zamboni, PharmD, PhD, has developed a probe to measure the body’s immune function to help physicians deliver accurate, individualized doses for cancer patients prescribed nanoparticle-based drugs
The inaugural geriatric oncology symposium, geared toward a lay audience, provided a lively afternoon of presentations, questions and answers, and concluded with a reception on Friday, November 15, 2013.
The award is the highest distinction awarded by the American Association of Pharmaceutical Scientists.
Der highlighted recent research findings that have stimulated new experimental directions for improve therapies for pancreatic cancer.
Women who are obese face an increased risk of developing an aggressive sub-type of breast cancer known as ‘basal-like’, according to research conducted at the University of North Carolina at Chapel Hill.
When celebrities battle cancer, their stories make headlines around the world. Whether announcing their prognosis, seeking treatment or losing their battle, celebrities faced with cancer have a profound impact on the public – one that leads to increased interest in cancer information and screening, according to research by the University of North Carolina.
Five questions for Greg Wang, a new Jefferson-Pilot fellow searching for better ways to shut down cancer cells.
In October 2013, Adam Goldstein, MD, MPH, embarked on an incredible journey taking him to the heartland of civilization's beginning.
Matthew Nielsen, MD, MS, FACS, presents on "Active Surveillance for Prostate Cancer" for the Global Grand Rounds hosted by Best Doctors.
Stereotactic body radiation therapy is an effective treatment option that is cost-effective and convenient for patients.
Book drive seeks 10,000th book for the Pediatric Oncology Clinic.
WCHL named Lisa Edwards a Hometown Hero for November 6, 2013. Each weekday the station selects a Hometown Hero who goes “over and above the call of duty,” exemplifying excellent service and dedication to others in the community.
The grant will be used to further research to globally understand regulated protein degradation and how this contributes to normal cellular functions that are dysfunctional in cancer.
GlaxoSmithKline drug-discovery competition winners aim to find a new cancer therapy and a novel way to regulate male fertility, projects spearheaded by scientists at the UNC School of Medicine.